US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 9.230
  • -0.250-2.64%
Close May 10 16:00 ET
  • 9.230
  • 0.0000.00%
Post 16:20 ET
2.73BMarket Cap-18836P/E (TTM)

Amicus Therapeutics Key Stats

Amicus Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

110.40M

+27.97%
EPS(YoY)

-0.16

+11.11%

Buy

May 10, 2024

Amicus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 133.498M--
--2024/Q2-- / 121.298M--
May 9, 20242024/Q1110.403M / 111.186M--
Feb 28, 20242023/Q4115.082M / 115.047M--
Nov 8, 20232023/Q3103.501M / 101.375M--
Aug 8, 20232023/Q294.503M / 89.868M--
May 10, 20232023/Q186.270M / 83.212M--
Mar 1, 20232022/Q488.096M / 87.761M--
Nov 7, 20222022/Q381.691M / 84.196M--
Aug 4, 20222022/Q280.731M / 85.883M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 133.498M--
--2024/Q2-- / 121.298M--
May 9, 20242024/Q1110.403M / 111.186M--
Feb 28, 20242023/Q4115.082M / 115.047M--
Nov 8, 20232023/Q3103.501M / 101.375M--
Aug 8, 20232023/Q294.503M / 89.868M--
May 10, 20232023/Q186.270M / 83.212M--
Mar 1, 20232022/Q488.096M / 87.761M--
Nov 7, 20222022/Q381.691M / 84.196M--
Aug 4, 20222022/Q280.731M / 85.883M--

Unlock Free Earnings Estimates

Amicus Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 10, 2024

Buy

  • Buy

    71.43%
  • Hold

    28.57%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg